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Abstract 
Significant computational efforts have been focused towards exposing the molecular mechanisms 
of anesthesia in recent years. In the last decade, this has been aided considerably by a momentous 
increase in the number of high-resolution structures of ion channels, which are putative targets 
for the anesthetic agents, as well as advancements in high-performance computing technologies. 
In this review, typical simulation methods to investigate the behaviour of model membranes and 
membrane-protein systems are briefly reviewed, and related computational studies are surveyed. 
Both lipid and protein-mediated mechanisms of anesthetic action are scrutinized, focusing on the 
behaviour of ion channels in the latter case.  
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1. Introduction 
Anesthesia refers to a medically induced lack of sensation, enabling surgical procedures to take 
place in the absence of pain. During general anesthesia, the patient encounters a state of paralysis 
in the whole body, accompanied by unconsciousness. During local anesthesia, specific parts of the 
body are insensitive to pain, whilst patients are responsive. The identification of anesthetic 
molecules has revolutionized the medical industry, yet an in-depth understanding of the molecular 
mechanism of anesthetic action has not yet been achieved. Initial examinations by Meyer and 
Overton led to the proposal of a lipid-mediated mechanism for anesthesia. 1,2 The early 
experimentalists revealed a notable correlation between the anesthetic potency and the solubility 
of molecules in oil, a lipid-like phase which is assumed to act as a simplified model of the 
membrane interior, advocating that anesthetics likely act via the plasma membrane. Studies of a 
variety of anesthetic compounds in an assortment of solvents have since been performed,3,4 and 
the Meyer-Overton hypothesis was upheld for nearly a century, until a number of notable 
exceptions were revealed. For example, Koblin and colleagues identified a series of 
polyhalogenated and perfluorinated compounds which displayed no anesthetic effect despite 
fulfilling the Meyer-Overton rule.5,6 On the other hand, the potency of short chains 1-alkanols was 
markedly underestimated by the rule.7  
Several alternatives have now been proposed to account for such exceptions. Pohorille et al. 
identified an improved correlation when interfacial solubilities were used instead of bulk lipid 
solubilities, suggesting anesthetic compounds act at the lipid-water interface.8 Furthermore, 
Cantor discussed various membrane properties that could potentially modify the activity of 
intrinsic membrane proteins, recognizing that the specific composition can influence the lateral 
pressure profile of the membrane.9,10 As the conformational equilibria of membrane proteins is 
mechanically coupled to the lateral pressure profile, incorporation of compounds into the bilayer 
may therefore shift the activation state of membrane proteins such as ligand gated-ion 
channels.9,11  The effect of stiffness and interfacial activity of anesthetic molecules on the pressure 
distributions was used in this context to predict the potency of alkanols previously classified as 
anomalous by the Meyer-Overton rule.12 
Alternative to the lipid-mediated theory, it has been postulated that anesthetics can act by directly 
binding to protein targets. Among early work, it was demonstrated that inhalational anesthetics 
directly inhibited the function of enzyme firefly luciferase by competitive binding of the 
substrate.13-15 Furthermore, anesthetics exerted an effect on soluble cytoplasmic proteins, such as 
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protein kinase C.16,17 Considerable efforts were then focused towards identifying specific protein 
targets. Nowadays, specific classes of membrane receptors and membrane channels are 
considered to be dominant targets for anesthetics. Targets include GABAA, glycine, nicotinic 
acetylcholine, glutamate, adenosine and serotonin receptors, as well as voltage-gated, ATP-
sensitive and background potassium channels.18 These proteins are generally considered to 
accommodate anesthetic molecules in pockets/cavities, which consequently modulate their 
structure and dynamics in a specific manner.19 Thereupon, a legion of works has been published 
with the aim of classifying interaction sites and determining the repercussions of binding on the 
structure and dynamics of the protein. 
Detailed understanding of membrane-ligand and membrane-protein interactions at an atomic 
level, and comprehension of the structural consequences of such binding, will greatly benefit 
future anesthetic drug design. In this review, we provide an overview of the achievements of 
computational tools for chemical biology in deciphering the molecular mechanism of anesthetic 
action. Firstly, a brief overview of common simulation methods used for the study of biological 
systems is given, and then we explore how such methodologies have been used to investigate 
both lipid and protein mediated theories. In the latter case, we focus on types of membrane-
channel systems, namely pentameric ligand gated ion channels and voltage-gated ion channels, 
which are both putative targets for anesthetics and have been studied extensively by 
computational means. We primarily focus on simulations based on high-resolution structural 
information, although homology models are mentioned where appropriate.  Finally, a critical 
outlook on the state of the field will be surmised.  
2. Common simulation methods 
The broad range of tools for computational chemistry that are currently available enable 
researchers to study a considerable variety of properties. On the molecular level, molecular 
dynamics (MD) simulations are a popular method to analyze the dynamic behaviour of chemical 
entities in atomic detail. A brief overview of MD simulations and related methods are provided in 
this section. Further information concerning the mathematical background can be found in various 
textbooks on the topic.20-22 To perform MD simulations, the underlying potential energy of the 
system must be calculated in the first instance, via quantum or molecular mechanical methods. In 
the latter case, atoms and bonds are considered as balls and springs, respectively, thus nuclear 
motion is evaluated using classical physics, and an analytical expression for the energy of a system, 
known as a forcefield, can be utilized. Inter- and intramolecular energetic terms, including bond 
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stretching, angle bending, bond rotations and non-bonded terms, contribute to the forcefield. This 
method in its simple version neglects electronic properties such as polarizabilities but permits the 
evaluation of a significant number of properties. Classical MD simulations are particularly suited to 
the study of biological systems, such as membrane proteins, due to the large number of atoms 
that are involved and the resolution of the events under investigation.  
In order to obtain information about the time-dependent behaviour, the motion of interacting 
particles is calculated by the integrating Newton’s equations of motion. The potential energy of 
the system, evaluated using the chosen forcefield, and the forces, evaluated using the negative 
gradient of the potential with respect to displacement in a specified direction, can be used to 
calculate the acceleration, and hence forecast the time evolution of the system, in the form of a 
trajectory. When few atoms are involved, analytical solutions of the equations of motion can be 
accessed, generating a continuous trajectory over time. In larger systems, this is unworkable due 
to a many body problem in force evaluations, from the existence of a continuous potential. 
Instead, finite difference methods can be used where forces are evaluated at discrete intervals 
(timesteps) assumed constant in the hiatus. Using the positions, velocities and forces of individual 
atoms at the current timestep, the position and velocities at the following timestep can be 
calculated. Forces are then recalculated, and the procedure is repeated until the desired timescale 
is reached.  
Algorithms for classical MD simulations are implemented in a wide variety of software (NAMD,23 
AMBER,24 and GROMACS,25 for example), which are compatible with a broad range of 
biomolecular forcefields (CHARMM,26 AMBER,27  OPLS28 etc.) Forcefields generally differ in their 
functional form, parameterization protocol and parameters therein, and are generally obtained to 
accurately reproduce of experimental and/or quantum mechanical data. Generally, individual 
terms for bond lengths and angles utilize simple harmonic potentials on the basis of an energetic 
penalty associated with a deviation from the equilibrium value.26 To model the rotation of atoms,  
a torsional angle potential function is also typical to associated steric barriers. To obtain the 
energy of non-bonded interactions in additive forcefields, fixed-point charges are assigned at the 
nuclei and Coulomb and Lennard-Jones potentials are used to express electrostatic and van der 
Waals forces respectively. In recent years, polarizable forcefields have become available, which 
take into account charge polarization effects. Multiple schemes have been proposed to take into 
account charge fluctuations, induced by the presence of additional molecules.29 The fluctuating 
charge model, the induced dipole model and the Drude oscillator approach, are available via the 
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CHeq forcefield,30,31 AMOEBA32  and the CHARMM Drude polarizable forcefield,33,34  respectively. 
Reference [32] is recommended as an encyclopedic update of the field.35 
The timescales that can be achieved by classical MD simulations are limited by the system size and 
availability of computing resources and efficient simulation algorithms. Simulations from 100 
nanoseconds to one microsecond are generally now routine for membrane proteins systems with 
between 100,000 and 500,000 atoms. Simulations of this time and length scale are therefore, 
suitable to study a broad-spectrum of biological processes. The supercomputer Anton and 
optimized MD software developed by D. E. Shaw Research, has enabled production of millisecond 
long unbiased simulations, further extending the phenomenon that can be considered.36  
In parallel, various methods have been developed to enhance sampling using typical high-
performance computing facilities.  In coarse-grained (CG) molecular dynamics, a reduced 
representation is used; by treating a group of atoms as a single interaction site, the number of 
degrees of freedom in a simulation system is reduced, alongside the calculation expense of each 
timestep. Furthermore, the timestep of each iteration is increased, facilitating the simulation of 
larger systems with increased complexity. Several CG forcefields have emerged in recent years, 
suitable for the study of biological systems.37-41 
Various methodologies also exist to calculate the free-energy of relevant biological processes.  
Free energy perturbation (FEP) is one such method, whereby unphysical alchemical 
transformations are performed to convert the system between thermodynamic states; free energy 
differences can then be calculated using a thermodynamic cycle.42,43 FEP is predominantly used to 
calculate to relative binding affinities between related compounds, which is computationally 
inexpensive compared to calculating absolute binding affinities.44 In this context, the free energy 
of difference of bound and unbound states is calculated e.g. ΔG1: M + L1  ML1 and ΔG2: M + L2 
 ML2. The relative free energy of binding can be obtained using the relation Δ(ΔG) = ΔG2 – ΔG1. 
Several other algorithms exist which accelerate sampling along a pre-defined set of reaction 
coordinates, known as collective variables (CV), to overcome energetic barriers and evaluate the 
free-energy of the chosen conformational transition, known as the potential of mean force (PMF).  
Umbrella sampling (US)45 is a common enhanced sampling method in this field. To sample a 
specific transition, independent MD simulations are performed at energetically distinct regions of 
the potential energy surface, maintained by a biasing potential.  These simulations, known as 
windows, are chosen to so that they overlap to some extent, and can then be combined and 
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unbiased using the weighted histogram analysis method (WHAM)46,47 or umbrella integration to 
obtain the underlying potential energy surface.48  
In steered molecular dynamics (SMD) simulations, an external force is applied to an atom or group 
of atoms, to overcome barriers and sample a specific process.49 Relative free energies can then be 
obtained by the Jarzynski’s equality, which relates the free energy difference between two 
thermodynamic states and work done for the interconversion between states.50 In 
metadynamics,51 a bias potential is also used to accelerate sampling along chosen CVs. Gaussian 
functions are added to CVs, which redirects the simulation away from low-energy configurational 
space that has been previously inhabited. In this manner, the system departs from local free-
energy minima, exploring barrier regions and locating alternative thermodynamic states. Once the 
free energy profile has been flattened, convergence can be achieved, and the free energy profile 
can be reconstructed to provide an unbiased estimate of the landscape as a function of the CVs. 
The adaptive biasing force method (ABF)52 is largely based on thermodynamic integration, 
whereby the instantaneous force along the reaction coordinate is evaluated directly and 
counteracted by an external biasing force of equal and opposite magnitude. This effectively 
provides a smooth energy landscape, and uniform sampling irrespective of energetic barriers 
allowing accelerated dynamics.  
Finally, we remark upon related methods which are applicable to the identification of binding sites 
in macromolecules. Molecular docking is an inexpensive tool to establish potential binding sites 
and predict the position, orientation and binding affinities of bound molecules. This is achieved by 
use of sampling algorithms to catalog possible ligand-receptor conformations, which are then 
ranked by scoring functions. Commonplace sampling and scoring algorithms and tools to perform 
molecular docking are reviewed elsewhere in the literature.53,54  It should be highlighted that 
molecular docking is not a simulation method and can be performed on a single core-processor, or 
via online servers. However, molecular docking is typically performed using a rigid receptor and 
flexible ligand, neglecting changes in protein structure which may influence the conformation of 
the ligand. Therefore, the accuracy of this method is inherently limited in comparison to 
simulation methodologies.  
“Flooding” is an alternative option, with greater computational expense and accuracy. In this case, 
an excessive concentration of ligand is inserted in the solution surrounding the protein target and 
allowed to enter favorable positions over the course of an unbiased MD simulation trajectory.55 
This approach implicitly takes into account fluctuations in receptor and ligand dynamics.     
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3. Anesthetic interactions with membranes. 
Investigations into the molecular mechanisms of anesthesia have historically been fixated on the 
interaction of anesthetic compounds and membranes, a legacy of the Meyer-Overton correlation. 
In the field of computation, initial studies followed this trend, with MD simulations becoming an 
established tool to investigate the atomic interaction between anesthetic agents and lipid bilayers, 
which act as a simplified model of the plasma membrane. Unbiased all-atom MD simulations have 
proven successful in characterizing the effect of anesthetics on the structural properties of lipid 
bilayers, with coarse-grained MD simulations used in a handful of cases.56,57 The first simulation 
study to compare bilayer properties in the presence and absence of an anesthetic, by Huang and 
coworkers in 1995, inserted a single trichloroethylene molecule into a bilayer constituted of 24 
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) molecules and an 8 Å layer of explicit water 
molecules to solvate the system.58  Moreover, enhanced-sampling methods are commonly used to 
calculate the free-energy profile of anesthetics crossing model membranes. In 1996, Pohorille et 
al. calculated the first free-energy profiles of membrane crossing for anesthetics, using one 
molecule of the closely related triflouroethane across a bilayer of 72 glycerol 1-monooleate 
molecules solvated by ~1000 water molecules.59 In the two decades since the initial publication of 
these studies, the significant advancements in computer software and hardware have enabled 
similar simulation protocols to be performed on larger systems with increased complexity on 
extended timescales. In several cases, such simulations have been used in conjunction with 
NMR,60,61 small-angle neutron scattering62 and X-ray scattering63 to determine the structural 
attributes of model membranes. An exhaustive list of publications of membrane-anesthetic 
simulations, categorized by compound and bilayer composition, can be found in Table 1. As is 
demonstrated, neutral one-component bilayers have primarily been used, although binary 
mixtures including charged species in symmetric or asymmetric distributions have now been 
reported.62,64-68 The double bilayer system was also employed in a recent publication to impose a 
concentration gradient and promote permeation within unbiased MD simulations.69 In this 
method, two bilayers are included in different planes of the z axis, to circumvent the effects of 
periodic boundary conditions, allowing different solute concentrations on alternate sides.  
Furthermore, analysis tools are now widely available, either within the simulation software itself 
as implemented in GROMACS, for example,25 or via additional plug-ins such as MEMBPLUGIN for 
VMD.70 Structural characteristics that can easily be monitored include, but are not limited to 
bilayer thickness, area per lipid, acyl chain segment order parameters, charge and mass density 
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distribution, electrostatic potential, interdigitation fraction, water dipole orientation, hydrogen 
bonding and lateral pressure profiles. Here, we review a number of common themes in the 
literature regarding anesthetic-membrane properties. 
Table 1. Survey of MD simulations studies performed of anesthetic agents and related compounds. Lipid 
types are abbreviated as follows:  DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), DMPC (1,2-
dimyristoyl-sn-glycero-3-phosphocholine), DPPC: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine and POPC 
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine).  
 
 
Type 
 
Name 
One-component Binary Mixtures 
DOPC DMPC DPPC POPC Other 
Local 
Anesthetics 
Articaine  71-73  74   
Benzocaine   75 76  64-66 
Benzyl Alcohol  77   60   
Bupivacaine    78   
Etidocaine    79   
KP-23    80   
Lidocaine  61,73,81,82 83    
Prilocaine    79,84   
Procaine  85 83    
Tetracaine  85 83    
General 
Anesthetics 
Alcohols 86 61,87,88 89  89  62,67 
Chloroform 68,90  91-94  90 68 
Diethyl Ether   91,93,94    
Enflurane   91,93,94    
Halothane 95 63,96-98 91,93,94,9
9,100 
101 102  
Desflurane    103   
Isoflurane     103,104   
Ketamine     105  
Propofol  106  103   
Sevoflurane    103   
Trichloroethylene
  
58      
Xenon 69  57,107  108,109  
Non-
Immobilizers 
Hexafluroethane  110,111   102  
A number of molecules have been identified which are structurally related to anesthetic 
compounds but exhibit negligible anesthetic properties despite displaying similar solubilities and 
fulfilling the Meyer-Overton rule.5,7,112 This has provoked considerable interest in differential 
responses of anesthetic and such ‘non-immobilizer’ molecules. Experimentally, it has been 
disclosed that anesthetic molecules modulate the orientational order of the hydrocarbon chains, 
whereas related non-immobilizer molecules produce little or no response.113,114 Observations from 
computation strongly agree with this postulate. Early calculations from Pohorille and colleagues of 
both classes of molecule in a simple lipid bilayer revealed anesthetic molecules preferentially 
reside near the headgroup-water interface, and non-immobilizer analogues can penetrate into the 
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hydrophobic membrane interior, in non-specific locations.59,115,116 MD simulations of halothane, in 
a saturated bilayer, confirmed this to be the case,99,100 identifying a number of perturbations in 
the structure of the lipid bilayer, such as an increase in area per lipid, a change in the orientation 
of the headgroup dipole and a decrease in the orientational order of the hydrocarbon chains, as 
predicted experimentally.113,114 Such changes were then absent in the presence of the halothane 
analogue, hexafluoroethane.110,111 These experiments were then repeated with highly unsaturated 
lipid bilayers, which are often present in biological membranes.102 The unsaturated systems 
displayed analogous distributions of compounds across the bilayer, with the exception of an 
additional minimum for halothane at the bilayer center and exhibited similar effects on the 
electrostatic profiles. Overall, the associated studies advocate that anesthetic and non-
immobilizer molecules occupy distinct locales in lipid bilayers, irrespective of the degree of chain 
saturation, a phenomenon which may underlie the discrepant responses to chemically similar 
molecules biologically. 
The protonation state of individual anesthetic molecules, which affect its biological activity, must 
be also considered, particularly for local anesthetics.117 Comparative simulations between charged 
and uncharged forms of local anesthetic molecules have been reported in a number of cases, with 
observable differences shown. Firstly, simulations of various neutral and charged KP-23 LA 
molecules in neutral and charged forms were performed.118 Neutral molecules partitioned into the 
bilayer core whereas charged molecules self-condensed on the bilayer surface, consistent with 
experimental studies demonstrating differential intercalation.119 In agreement with this, charged 
lidocaine molecules stably occupied the lipid headgroup region in a DMPC (1,2-dimyristoyl-sn-
glycero-3-phosphocholine) bilayer primarily oriented parallel to the bilayer normal, whereas 
neutral molecules can penetrate further and move more freely in a perpendicular orientation.81 In 
a subsequent study, the neutral and charged lidocaine molecules were found to modify the 
electrostatic potential profiles to a similar extent, despite alternate positions and the associated 
effects. It was then suggested changes of this magnitude (90 mV for 9 mol % of lidocaine and 220 
mV for 28 mol % of lidocaine) could potentially alter the function of voltage-gated ion channels.82 
Using the same simulation protocol, articaine charged and uncharged molecules were observed to 
accumulate in analogous positions and crossing to a similar extent as those observed in 
lidocaine.71 However, critical differences are observed in the orientation of the charged form, now 
parallel to the membrane surface, and the hydrogen bonding and diffusion attributes, resulting 
from an additional carbonyl group at the opposite end of the molecule, and causing differential 
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effects in the membrane physical properties. The effect on the electrostatic potential profile was 
also similar for both forms, again of the order of the transmembrane potential. What emerges 
from such studies is clear evidence that charged molecules preferentially bind to the headgroup 
regions whereas neutral molecules penetrate the hydrophobic region of the bilayers more readily. 
Consequentially, the impact of anesthetic intercalation on the structural properties can differ. 
Efforts have also been focused towards understanding the effects of pressure on general 
anesthesia, in order to rationalize the known pressure reversal, i.e. the inverse correlation 
between pressure and anesthesic potency.120,121 Computational simulations have been used to 
evaluate the effect of pressure on the behaviour of anesthetic molecules, although other 
mechanisms of pressure modulation may exist in this context. Using halothane in artificially high 
concentrations, six times the clinical concentration, MD simulations by Chau et al. revealed 
elevated aggregation of halothane at high pressures in DMPC (1,2-dimyristoyl-sn-glycero-3-
phosphocholine)  bilayers.96,98 The authors suggest preferred accumulation disfavors binding of 
individual halothane to putative binding sites on intrinsic membrane proteins. At a lesser 
concentration, twice the clinical concentration, and using an alternative membrane (POPC: 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), Tu and coworkers disclosed halothane 
aggregation at  2 x107 Pa, but not at 4x107 Pa, consistent with conditions where pressure reversal 
is observed and inhibited.101 In contrast, such clustering of isoflurane molecules in lipid bilayers is 
not observed at elevated pressures, suggesting previous results may be isolated examples, and 
therefore an alternative mechanism may be in action.104 The question of pressure reversal will 
likely spawn numerous studies in the near future.  
The noble gas xenon has been of considerable interest as a general anesthetic in recent years.122-
124 Although the clinical benefits of xenon have been known for decades,125 the feasibility of the 
gas has been newly realized with lowered costs.122 However, the mechanism of xenon remains 
elusive. Xenon is known to elicit a response in certain glutamatergic receptors,126,127 nicotinic 
receptors128 and potassium channels,129 yet is ineffective on GABAA receptors,126 a significant 
anesthetic target. Thus, computational efforts have been focused towards assessing the viability of 
the membrane-mediated mechanism of anesthetic action for xenon. The ramifications of xenon 
penetration on bilayer properties, pressure coupling and comparative studies of similar chemical 
species lacking anesthetic activities have been extensively assessed in this case. 
Initial simulations of xenon in POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), bilayer 
identified slight increases in both area per lipid, membrane thickness and orientational order of 
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the lipid tails, as a result of xenon occupation of the interfacial region and in the center of the 
bilayer.107 In a POPE bilayer, increases in area and volume per lipid and decreases in the 
orientational order of acyl chains were observed in the presence of xenon alongside increased 
diffusivity of the lipid molecules.109 The simulations conducted at a number of pressures (0.1, 10, 
20, 35, and 50 MPa) reveal xenon molecules are pushed into the interface between the two 
bilayer leaflets at high pressures which limits their diffusion. Comparable properties are observed 
in these bilayers and xenon-free bilayers at low pressure, advising that pressure reversal emanates 
from the elimination of diffusive xenon molecules in the membrane. Differential scanning 
calorimetry measurements combined with MD simulations confirmed favorable binding in the 
bilayer core, promoting straightening of the lipid tails concomitantly with increased head-group 
spacing.69 Biophysical properties were also perturbed, such as the decrease in phase transition 
temperature and the lateral pressure profile in the head group region, adhering to the lipid-bilayer 
mediated mechanism of general anesthesia proposed by Cantor.130 This proposal was supported 
further by a comparative study of four noble gases (Ne, Ar, Kr and Xe), which found that the 
degree of disruption of the membrane was dependent on the site of localization, and correlated 
well with their relative narcotic potencies.108 Booker and Sum hypothesize that the modified phase 
transition temperature, lateral forces and hydrophobic mismatch caused by accretion of xenon in 
the membrane can contribute to the conformational cycle of ion channels embedded in the 
membrane, providing multiple indirect mechanisms of action.69 The authors note that the 
suggested membrane-mediated mechanism for xenon likely contributes to an additional protein-
mediated mechanism.  
4. Anesthetic interactions with ion channels. 
4.1 Pentameric ligand-gated ion channels or “Cys-loop” receptors. 
Ion channels facilitate the passive diffusion of ionic species down their electrochemical gradient 
from the extracellular medium into the cell cytoplasm. Permeation is controlled by the onset of 
various external stimuli, such as transmembrane voltage, heat, ligand binding, and mechanical 
stretch, and is responsible for regulating electrical signals across the cellular membrane. 
Pentameric ligand-gated ion channels (pLGICs) are responsible for the swift conversion of chemical 
signals to electrical impulses throughout the nervous system.131 pLGICs from the Cys-loop receptor 
family have been identified as a putative target for general anesthetics at clinical concentrations, 
with the exact response, inhibition or potentiation), dependent on the channel type.132,133  
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Extensive work on nicotinic acetylcholine receptors revealed the overall structural assembly of 
pLGICs, contain five homologous or closely related heterologous subunits which assemble in a 
pentameric arrangement.134 Each subunit contain N- and C-terminal extracellular domains, and 
cytoplasmic and transmembrane domains.134 Orthosteric and allosteric binding sites are located in 
the extracellular domain, alongside the characteristic “Cys-loop”, a thirteen-residue loop flanked 
by cysteine residues engaged in a disulfide bond.135 The symmetry axis of the transmembrane 
domain constitutes the ion permeation pathway, formed from four transmembrane segments 
(M1-M4); M2 lines the central pore and a cytoplasmic domain of variable length intersects 
segments M3 and M4.  
The discovery of prokaryotic homologues of pLGICs hastened the publication of high-resolution 
crystal structures pLGICs, with pLGICs from Erwinia chrysanthemi (ELIC)136,137 and Gloebacter 
violaceus (GLIC),138,139 the first to become available and representing closed and open states, 
respectively. The structures consist of a homologous transmembrane domain (M1-M4) and an 
expansive extracellular domain composed of five inner and three outer strands connected by 
loops forming a ß-sandwich. The susceptibility of the prokaryotic homologue from Gloeobacter 
violaceus (GLIC) to clinically relevant concentrations of GAs has also been established.140 
Therefore, such structures provide a rational study point to study the molecular mechanism of 
anesthetic action by computational means. Due to the number of simulation studies on the GLIC 
channel, and the availability of high-resolution crystal structures of the GLIC, we will focus on this 
channel although it should be noted that other Cys-loop receptors, such as the glycine 
receptor,141-143 the nicotinic acetylcholine receptor (nAChR)144-146, the GluCl channel147 and the 
GABAA
148-151 receptor, have been the subject of computational works, primarily using homology 
models. 
Initial computational works utilizing the apo structures of GLIC aimed to identify anesthetic 
binding sites.55 Brannigan et al. performed a comparative study of isoflurane binding to nAChR and 
GLIC, implicating eight distinct sites, throughout the transmembrane and extracellular domains, 
and within the interfacial region between the two.55 Of potential functional relevance, the pore of 
both LGICs accommodates isoflurane dimers which would impose a physical block to ion 
permeation, thus acting as an inhibitory site. Isoflurane also binds to the TM domain of nAChR in 
intersubunit sites underneath the M2-M3 loop in nAChR, in agreement with earlier speculation 
from photoaffinity labelling.152 The absence of such a site in GLIC leads the authors to postulate 
this acts as a positively modulating site, rationalizing the increased sensitivity of GLIC to inhibition 
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by anesthetics, relative to nAChR.140 Finally, novel intrasubunit sites in both α nAChR subunits, and 
one α GLIC subunit, were observed. It is speculated that residence of the α subunits, which 
determine agonist susceptibility, in a position behind the M2 helices, which are involved in 
channel opening, and parallel to the hydrophobic constriction, could influence the active state of 
the receptor. 
Various crystal structures have since been resolved of GLIC in complex with anesthetic molecules, 
including propofol,153,154 desflurane,153 bromoform,154-156 ethanol155 and ketamine,137 providing 
additional insights into sites in the transmembrane and extracellular domains, and in the pore 
(Figure 1). A transmembrane anesthetic binding site was characterized in the 2011 structure of 
GLIC in complex with GAs propofol and desflurane.153 Here, the compounds occupy an 
intrasubunit crevice in the extracellular leaflet of the transmembrane domain, with residues from 
M1-M4 and β6–β7 loop of the extracellular domain. Mutants T255A (M3) and V242M (M2) 
displayed a marked, albeit distinct, response to propofol and desflurane, confirming the 
physiological importance of such a site. Increased propofol sensitivity was interpreted by MD 
simulations within the same study, as propofol percolated further into the cavity, becoming less 
mobile and intensifying interactions with residue 242 in mutant channels relative to the wild type. 
 
Figure 1. Position of propofol (blue), isoflurane (purple) and ketamine (green) binding sites in 
GLIC/ELIC obtained from PDB files 3P50,153 4Z90157 and 4F8H,158 respectively. Transmembrane 
helices of a single subunit are colored yellow to orange, with the extra cellular domain shown in 
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red. 
Using the crystallographic positions of desflurane, as a reference, and additional molecular 
docking calculations, Willenbring and coworkers simulated isoflurane binding to GLIC to delineate 
the structural consequences of prolonged binding.159 Movement of isoflurane between sites 
promoted the breakage of intersubunit salt bridges in the extracellular domain, perturbing the 
quaternary structure and inward movement of the M2 helices, providing a mechanism by which 
isoflurane contributes to channel closure.  
Subsequent MD simulations revealed loose binding of the resolved desflurane to the crystal 
structure site, which could dissociate in under 100 ns.160 However, occupation of an adjacent site 
enhanced binding suggesting double occupation is required for desflurane to inhibit GLIC. 
Mutation in this site experimentally correlated with diminished binding in the crystal structure 
site, in agreement with this. The route of access of such sites is also exposed, with desflurane 
diffusing into and out of the site through the membrane, via the protein-membrane interfacial 
region. 
Further to this, fluorescence quenching disclosed the presence of multiple binding sites for inhaled 
anesthetic halothane and the intravenous anesthetic thiopental in the transmembrane domain.161 
Simulations revealed a site in close proximity to N200, near M1 and the M2-3 loop, which was 
confirmed by mutagenesis of this residue, and multiple additional sites. Some sites overlapped to 
some extent for the chemically distinct compounds and could therefore quench the same 
tryptophan residues. Halothane bound in the M1-M23 site stabilized the M23 loop whilst 
mobilizing the Cys-loop in the EC domain, two regions implicated in channel gating in pLGICs.162-164 
Binding of halothane near W160 at the EC-TM disrupted critical salt bridges, such as D32-
R192.161,165 Removal of the analogous salt bridges in other ligand-gated ion channels notably 
diminished the stability of the open state,164,166,167 suggesting occupation of this site may exert a 
similar effect in GLIC. 
Transmembrane binding was also observed for propofol via flooding simulations using coarse-
grained methods which accessed a multi-microsecond timescale.168 GLIC channel dynamics with 
partial occupancy of propofol binding site was investigated by Mowrey et al.169 Asymmetric states 
with one to three sites inhabited exhibited elevated channel dehydration relative to symmetric 
states with zero or five molecules bound. Conformational changes were observed in the 
 15 
 
asymmetric states, consistent with the known effects of asymmetric agonist binding in homo-
pLGICs.170-172 
With regards to a potential pore-binding site, crystal structures of GLIC bound to bromo-lidocaine, 
a lidocaine analogue provided the first structural insights into a pore-binding site in pLGICs.173 
Computationally, isoflurane was also documented to pass through the closed hydrophobic gate,159 
in spite of dehydration of the central cavity, occupying a position between residues I233 and I240, 
supporting earlier theoretical and experimental evidence of pore-binding in GLIC.55,173 LeBard et 
el. performed a systematic study of binding to the GLIC pore,174 using monomers and dimers of 
both isoflurane and propofol, in addition to ethanol as a negative control. Isoflurane binding 
affinities, calculated using FEP, were contingent on the functional state of the pore, with a 
situation involving binding of two isoflurane molecules to the closed pore resembling the 
micromolar affinity determined experimentally, and consistent with a pore-block mechanism. The 
determined affinities illustrated that the effect of propofol is overestimated when considering a 
pore-block mechanism in isolation and support a mechanism where pore and allosteric sites exert 
competitive effects on the functional state of the channel.175 
These conclusions were further supported by the high-resolution structure of ELIC co-crystallised 
with isoflurane, in both apo and agonist bound forms, presumed to be in resting and desensitized 
activation states, respectively.157 These structures show inhabitancy of two isoflurane molecules 
within the pore, with MD simulations in the same study revealing paramount stability in the ELIC 
resting state, as a result of observable changes in the pore radii along the channel. Nevertheless, 
the affinity for both states suggests isoflurane can act by stabilizing the closed channel and also 
obstructing the open channel. The structural and dynamical information presented throughout 
these works strongly supports a pore-binding mechanism of inhibition. Bromoform binding has 
also been observed in the pore of GLIC, experimentally and computationally.155,156 
Finally, structural information has also revealed a binding site in the extracellular domain. The 
crystal structure of R-ketamine in complex with GLIC exhibits symmetric binding in extracellular 
intersubunit cavities.137 MD simulations confirmed the observed stereospecifity of this site, with S-
ketamine unable to interact with residue D154, which stably interacts with R-ketamine.176 Notably, 
R-ketamine evolved into asymmetric binding poses over the course of the trajectories, in contrast 
to the known symmetric structures of pLGICs in complex with anesthetics.137,153,155 Structural 
differences resulting from R-ketamine binding was propagated to the ECD-TMD interface and to 
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pore-lining helix M2, via either the pre-M1 region or the EC β1–β2 loop.176,177 In coarse-grained 
simulations by Joseph and Mincer, mentioned previously, propofol spontaneously occupied the 
crystallographic extracellular binding site, prompting asymmetric conformational changes in GLIC, 
transmitted through a similar allosteric network in the ECD-TMD interface.168 The molecular 
mechanism of long-range allosteric coupling was further probed by coarse-grained MD 
simulations, using a novel elastic network model proposed by Li and colleagues.178 
Overall, a myriad of anesthetic binding sites have been proposed by both experimental and 
simulation methods for the GLIC channel. Consequently, uncovering the molecular mechanism of 
anesthetic action has proven difficult. Several studies of GLIC with a number of different 
anesthetics reported a degree of structural asymmetry during the inhibition of GLIC by 
anesthetics. 
4.2 Voltage-gated ion channels 
The voltage-gated ion channel (VGIC) family that specifically conduct Na+ (NaV) and K
+ ions (KV) 
implements critical actions in the generation and propagation of action potentials, and thus, plays 
a crucial physiological role. VGIC’s are a common target for antiarrhythmic agents, local 
anesthetics, anticonvulsants and pain therapeutics.179,180 Anesthetics are known to block both NaV 
and KV currents at clinically relevant concentrations.
181,182 Various computational studies have 
been performed to investigate this phenomenon on a molecular level. 
The first high-resolution structure of the pore domain of an ion channel, the KcsA channel from 
Streptomyces lividans, was revealed in 1998.183 The protein is characterized by a symmetric 
tetrameric arrangement with each monomer containing two transmembrane α-helices and an 
intermittent pore loop. The pore loop contains the signature selectivity sequence, which 
determines the ionic permeability of the channel, and thus has become known as the selectivity 
filter.184,185 Between the selectivity filter and the cytoplasm, a water-filled cavity is present to 
provide an ideal environment for ion transfer.186 In K+ channels, the selectivity filter is constituted 
of a conserved amino acid sequence arranged to form rings of oxygen atoms, which are able to 
bind dehydrated ions in a cage-like structure, in adjoining sites. In Na+ channels, a ring of residues 
at the extracellular site forms the selectivity filter, although the identity of residues is more 
dependent on the specific channel. Atomistic structures of bacterial (KvAP from Aeropyrum 
pernix)187,188 and mammalian (Kv1.2) 189-192 KV channels have since been obtained, illuminating the 
structure of voltage-sensor domains (VSD) and their interaction with the pore domain. In contrast, 
high-resolution crystallographic data of NaV channels has been only available since 2011 from a 
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number of bacterial sources: NaVAb (Arcobacter butzleri),
193-196 NaVRh (Rickettsiales sp. 
HIMB114),197,198 NaVMs (Magnetococcus sp.)
199-201 and NaVAe1p (Alkalilimnicola ehrlichii sp. 
nov.)202. These channels exhibit four identical subunits arranged symmetrically, each containing six 
transmembrane segments (S1-S6). S1-S4 constitute the voltage-sensing domain, whilst S5-S6 
segments represent the pore domain, described previously. The behaviour of the voltage sensor 
and pore domains are closely coupled, whereby movement of S4 (following a change in the 
transmembrane voltage) prompts rearrangement of the pore helices, via the S4-S5 linker, 
subsequently opening the cytoplasmic gate. Recently, a cryo-EM structure of a eukaryotic NaV 
channel, NaVPs, at near-atomic resolution (3.8 Å), isolated from the American cockroach 
Periplaneta Americana has been published.203 This channel is comprised of a single polypeptide 
chain which is arranged into equivalent homologous transmembrane domains, as is the case for 
eukaryotic NaV channels. The overall homology observed between known eukaryotic and 
prokaryotic structures advocates bacterial analogs are suitable templates to study small-molecule 
inhibition of KV and NaV channels.  
4.2.1 Sodium Channels 
The therapeutic value of NaV channel inhibitors is well-established, with antiarrhythmics, 
anticonvulsants, antidepressants and antiepileptics known to block the NaV channel pore. Various 
anesthetic agents, including but not limited to isoflurane,204,205 lidocaine206 and bupivacaine206 are 
also known to modulate the entire mammalian NaV channel family. The effect of local anesthetics 
on sodium currents was first acknowledged by Weidman in 1955.207 This idea was matured by 
various researchers into the 1970’s, leading to the proposal of several mechanisms of anesthetic 
action on NaV channels.
208 Making use of data on NaV channel blockage by quarternary derivatives 
of lidocaine in myelinated nerves, Strichartz established the concepts of “tonic” and “use-
dependent” block, whereby drug molecules specifically bind to the closed and open state of the 
channel, respectively.209 At this time, factors including the structure/protonation state of the 
molecule, the mode of application and the membrane potential were found to alter the exact 
contribution of each mechanism to the observable response of individual anesthetics.210 
Nowadays, it is widely accepted that highly polar or charged compounds are effective during use-
dependent block traversing through a hydrophilic pathway, whereas neutral compounds are 
effective during tonic block, passing through a hydrophobic pathway when applied from either 
side of the membrane.208,211  
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The question of an alternative hydrophobic pathway was answered to some extent by the 
available structural information, which revealed lateral lipid-filled openings, termed fenestrations, 
directly connecting the central pore to the surrounding membrane, illustrated in Figure 2. 
Considering this, computational methods have been used to investigate small-molecule binding 
sites in NaV channels and potential access pathways for those within the pore.  
 
Figure 2. Pore structure of the NaVMs channel, with the individual fenestrations colored in blue, 
red, yellow and green. Each of the four monomers is represented in grey. The view of the channel 
is perpendicular to the membrane plane. 
The first prokaryotic NaV channel to exhibit a response to anesthetics,
212 NaChBac, has been the 
subject of several computational works.213,214 Homology models of NaChBac, based on a NavAb 
structure (PDB ID: 3RVY), in combination with flooding simulations, were used to identify multiple 
binding sites for the general anaesthetics isoflurane and sevoflurane.213,214 Sites were located near 
the selectivity filter accessible from the extracellular solution, at the S4-S5 linker, in the central 
cavity and at the entrance to the fenestration regions. The isoflurane sites with estimated binding 
affinities of the isoflurane interaction sites were calculated to be in the physiologically relevant 
range using FEP,213 with those beneath the selectivity filter and near the S4-S5 linker were later 
confirmed by NMR data.215 Evidence for state-dependent binding of sevoflurane to the S4-S5 
linker and selectivity filter site was also presented in the study by Barber and coworkers, alongside 
a unique site in the deactivated state where the S6 helices coalesce.214 The specific locale of the 
observed isoflurane and sevoflurane binding sites suggests that GAs may act by interfering with 
the selectivity filter, activation at the cytoplasmic S6 gate or by obstructing ion permeation within 
the pore, in a similar manner to local anesthetics in the latter case.213 Isoflurane and sevoflurane 
molecules were able to enter the central cavity via fenestrations, bypassing the closed cytoplasmic 
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gate. Entrance of such molecules was accompanied by displacement of fenestration-bound lipid 
molecules, the expulsion of water molecules through the selectivity filter, with approximately six 
water molecules displaced by a single isoflurane in the pore. These observations demonstrated 
the capability of fenestrations to act as a hydrophobic pathway for small drugs such as 
isoflurane.213  
Lending further support to this postulate, Kaczmarski and Corry used unbiased MD simulations to 
analyze the behaviour of fenestrations on the subunit-interface between S5 and S6 helices in six 
bacterial NaV channels and a homology model of NaV1.4, observed.
216 The bottleneck radii of the 
fenestrations range in size from 1.6 to 2.2 Å, with a maximum radii between 2.6 to 2.8 Å, 
potentially tolerable for the passage of aromatic rings, a typical component of NaV channel 
inhibitors. Fenestration size was determined by the identity (F203 in NaVAb, whereas the 
equivalent positions in NaVRh and NaVMs is occupied by Ile and Met) and rotameric state of 
bottleneck residues and the extent of lipid occupation, with local fluctuations typically observed 
on a nanosecond timescale. Following this, fenestration characteristics in the NaV1.4 channel 
model varied as a result of the sequential differences of the repeat sequences. 
The location of small molecule binding has also been of interest, utilizing the high-resolution 
structure of bacterial channels. Studies from independent research groups have identified two 
high-affinity binding sites for small neutral drugs, the local anesthetic benzocaine and the anti-
epileptic phenytoin, in the central cavity of NaVAb, using unbiased and metadynamics 
simulations.217 The observed binding occurs in two hydrophobic sites in the pore, in close 
proximity to the S6 gate and in a fenestration site, consistent with residues recognized in blocking 
of eukaryotic channels.218 Using extensive equilibrium simulations, Boiteux and coworkers cite 
enhanced stability of the fenestration site as a result of π-stacking with F203; on the other hand, 
Martin and Corry advocate non-specific hydrophobic interactions dominate binding in such sites, 
with the S6 site deemed more energetically favorable (by 3 kcal/mol)  using metadynamics 
simulations. These results are in agreement with prior studies implicating multiple residues which 
are hydrophobic in nature in tonic block,219 which is in stark contrast to use-dependent blockers 
which rely on cationic interactions with aromatic residues.219 Spontaneous translocation of 
benzocaine through the fenestrations is observed in the unbiased simulations, with low energy 
barriers of this route calculated by enhanced-sampling methods, confirming the fenestrations as a 
viable access route for the local anesthetic benzocaine. Unexpectedly, transfer of compounds 
through the closed cytoplasmic gate was noted to be viable in both studies. To imitate the 
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eukaryotic NaV channel pore, aromatic residues were introduced into the NaVAb pore near the 
activation gate, pushing benzocaine and phenytoin towards the fenestration site whereas 
aromatic residues near the fenestrations imposed the opposite effect. Interestingly, the binding 
affinity increased in such channels.220  
In the NAVMs channel, Buyan et al. characterized the transport and binding properties of a 
selection of physiologically active compounds, permanently neutral (benzocaine, lamotrigine, and 
carbamazepine) and protonatable (PF-5215786, PF-6305591, and lidocaine) in both neutral and 
charged states at pH 7, using unbiased MD simulations and the replica exchange with solute 
scaling/tempering method.221 Protonatable compounds penetrated the bilayer with ease in the 
neutral form, relative to their charged protonated form, advocating such molecules relinquish 
their charge before entering the plasma membrane. Once within the lumen of NaVMs, binding of 
neutral and charged molecules manifests at separate sites: neutral compounds primarily occupied 
the lower region of the pore proximal to S6 residues, whilst charged compounds displayed 
prominent interactions with the selectivity filter. In the latter case, sodium currents were 
hampered by steric block and electrostatic repulsion with the bound molecule. This novel, pore-
blocking site correctly reproduces the position of the resolved bromines in the crystallographic 
structure of NaVMs with antagonist PF-5215786,
200 and suggests compounds reclaim their charge 
to exert an effect in the pore.  
4.2.2 Potassium Channels 
Both voltage-dependent and voltage-independent K+-channels can be blocked by local anesthetics. 
Responses have been recorded for members of the two-pore domain222 and inward rectifying 
channels.223 An initial MD study of open and closed conformations of KirBac1.1 in the presence of 
halothane molecules demonstrated accumulation of halothane molecules at the cytoplasmic gate, 
in the open state only.224 Occupation of this region dampened movements of phenylalanine 
residues, which have previously been implicated in channel gating.225 A similar mechanism 
whereby halothane moderates tryptophan fluctuations has been proposed by fluorescence 
experiments226 and MD simulations alike.227,228 
The potential role of Kv channels in the action of inhalational general anesthetics has been 
realized most recently,229 with evidence accumulating from the 1990’s.230-234 A direct link between 
the application of isoflurane and the single-channel properties of Drosophila Shaker B KV channel 
was first established by Li and Correa.231 Inhibitory responses to general anesthetics (chloroform, 
halothane, isoflurane, and propofol) and short-chain alcohols have also been recorded for K-
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Shaw2, a distinct member of the Drosophila Shaker KV channel family.
235-237 Distinctively, 
sevoflurane triggered activation of K-Shaw2.238 Contrary to typical K+ channels, K-Shaw2 is thought 
to undergo a simple activation cycle, involving only two239,240 or three states.238 Consolidation of 
the accrued data advocate inhibitory compounds sustain closed states of the K+ channel, whereas 
sevoflurane is proposed to eradicate unstable inactivated states which diverge from the activation 
pathway.238 
In order to examine pore-binding sites in voltage-dependent channels, MD simulations of the open 
state Kv1.2190,191 and KCa3.1 (a homology model using the Kv1.2 structure) were performed with 
local anesthetic lidocaine and TRAM-34 initially inserted in the pore.241 Both compounds occupy a 
conserved valine-alanine-valine motif in the pore in both channels, in close proximity to the 
selectivity filter, in agreement with interaction sites predicted for small molecule binding in other 
K+ channels.242,243 Kd values were estimated as 20 μM (lidocaine-Kv1.2), 540 nM (TRAM-34–Kv1.2), 
and 10 nM (TRAM-34–KCa3.1), in broad agreement with experimentally determined values, and 
the recorded ∼200-fold selectivity of TRAM-34 for KCa3.1 over Kv1.2.244 The PMF profiles of ion 
permeation through Kv1.2 were then calculated, in order to delineate the functional consequence 
of pore binding to this site. The neutral form of lidocaine had negligible effect on the calculated 
energetics, whilst the charged form imposed an energy barrier of the order of 6kT, consistent with 
previous reports.245 On the other hand, TRAM-34 prompted ion dehydration, inducing an energy 
barrier of ~10 kT. As a consequence, lidocaine must be neutral to cross the membrane and enter 
the pore yet be charged to exert an effect. In contrast, the neutral form of TRAM-34 is sufficient 
for both purposes, providing a potential scaffold for drugs which would remain active in acidic 
conditions typical of inflammation. 
Various experimental results have also cited the involvement of the S4-S5 linker and the distal part 
of the S6 segment, and adjacent helices in the inhibition of K-Shaw2 by general 
anesthetics.236,237,246,247 The region is critical for coupling between the voltage-sensor and pore 
domains in the event of voltage activation, and it is therefore possible that anesthetic binding 
interferes with this phenomenon.191,248 In order to provide a molecular description of this 
phenomenon, Barber and colleagues performed a systematic alanine/valine mutagenesis scan to 
the S4-S5 linker and a segment of S6 on K shaw2, with associated electrophysiological experiments 
to delineate the consequences of such mutations on K-Shaw2 inhibition by 1-butanol and 
halothane.249 In conjunction with docking calculations and MD simulations, a putative anesthetic 
binding site in this region was identified in the S4-S5 linker region, with residues critical for either 
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anesthetic binding, allosteric coupling to the binding site and propagating structural changes to 
the cytoplasmic gate determined. A molecular picture of closely associated, yet distinct binding 
and effector sites emerged, beginning to unravel the determinants of anesthetic action to K-
Shaw2. 
Following this, the differential effects of the several general anesthetics and the novel potentiator 
sevoflurane on Kv1.2 and Kv1.2-FRAKT chimera (where the S4-S5 linker was replaced with that 
from K-Shaw2) were characterized.250 The output of such experiments demonstrated that discrete 
substitutions in the S4-S5 can induce startling differences in the response of KV channels to general 
anesthetics. More specifically, positive modulation of the Kv1.2 channel was predominantly 
dependent on a single mutation, G329T, with the mutant response closely resembling that 
displayed by K-Shaw2. Docking and free-energy methods utilizing closed/resting and 
open/activated states,251,252 identified four sites in the wild-type and G329T mutant, two involving 
the S4-S5 linker, one at the S5-S6 helical interface and one in close proximity to selectivity filter.250 
The selectivity filter sites displayed the highest affinity binding, and a single site at the S4-S5 linker 
displays noticeable dependence on the active state. Identification of several sites in the linker 
region with low binding affinities is consistent with a multi-site model for positive allosteric 
modulation of KV channels by sevoflurane. Further evidence was provided on this subject by Stock 
et al., who proposed a novel theoretical framework to study concentration-dependent 
interactions of ligands to multiple saturable sites in membrane receptors, based on docking and 
FEP calculations.253 
5. Outlook 
The molecular mechanisms of anesthesia have been the source of significant debate since the turn 
of the twentieth century. The Meyer-Overton hypothesis suggested anesthetic agents primarily 
act via the lipid membrane. However, various datum have been interpreted to disprove it, 
motivating alternative postulates. The evolution of computational protocols over the last two 
decades has permitted the study of both membrane and protein-mediated theories via molecular 
dynamics simulations, revealing dynamic characteristics of relevant biological processes at atomic 
resolution and applicable timescales. 
Several lines of inquiry have provided notable success, such as the assessment of the modification 
of structural properties of lipid bilayers following anesthetic exposure, and the identification of 
anesthetic binding sites on intrinsic membrane proteins, most notably pentameric ligand-gated ion 
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channels and voltage-gated cation channels. High-resolution structural information of bacterial 
analogs has proven indispensable in this case, providing a practical starting point for 
computational works. Concurrently, the publication of structures of pharmacologically relevant 
membrane proteins in the future will provide additional opportunities for researchers to perform 
simulation studies of this nature, for instance, in transient receptor potential channels.254 
Substantial advancements in high-performance computing facilities, simulation algorithms and 
forcefields required for the study of model membrane systems have also significantly contributed 
to the success of this field. Further improvements in computer hardware will likely be achieved at 
an unprecedented rate, continuously improving the timescales that can be reached by simulation 
methods.  
Several pertinent questions remain to be addressed. Exactly how direct and indirect effects 
influence the activation state of known targets, and hence evoke a physiological response has 
proven difficult to discern. Furthermore, detailed information regarding the subtype selectivity of 
known anesthetic compounds could be exploited to optimize compounds in the design of novel 
anesthetic compounds. It is likely that models accounting for the combined effect of small-
molecule binding and membrane perturbations will emerge in the near future. 
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